Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 179 publications
Linezolid Acts as a Selective Inhibitor of the JAK2 V617F Mutation.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms.
Journal: Leukemia
Published: June 08, 2026
Long term outcomes of idasanutlin therapy in hydroxyurea-refractory polycythemia vera patients.
Journal: Leukemia & lymphoma
Published: May 18, 2026
Targeting nuclear export and Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signalling in myelofibrosis: A novel combinatorial strategy that impacts intrinsic and microenvironment-related pathways.
Journal: British journal of haematology
Published: May 06, 2026
Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.
Journal: Blood
Published: March 13, 2026
Inhibition of the EBF1-ITGB8 Axis in Bone Marrow Niche Ameliorates Hallmarks of Myelofibrosis.
Journal: bioRxiv : the preprint server for biology
Published: February 27, 2026
Menin-dependent megakaryocyte proliferation and fibrosis in myeloproliferative neoplasms.
Journal: Cancer cell
Published: September 30, 2025
Sequential treatment with ruxolitinib and imetelstat effectively depletes myelofibrosis hematopoietic stem and progenitor cells.
Journal: Leukemia
Published: September 29, 2025
Artificial intelligence differentiates prefibrotic primary myelofibrosis with thrombocytosis from essential thrombocythemia using digitized bone marrow biopsy images.
Journal: Leukemia
Published: August 20, 2025
Last Updated: 09/26/2026